Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn Pharmaceutical Technology 10:14 Fri, 08 May
Family-Run Angelini Pharma Buys Catalyst Pharmaceuticals For Over 4 Billion Benzinga 17:00 Thu, 07 May Article paywall
STAT Plus: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B STAT 09:43 Thu, 07 May